Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × PM 01183 × Clear all

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 20 Observational 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Surveys and Questionnaires 526 Blood Specimen Collection 402 Surgical Procedures, Operative 148 Interviews as Topic 130 Radiotherapy 128 Drug Therapy 120 Observation 114 Magnetic Resonance Spectroscopy 104 Biopsy 103 Specimen Handling 70 Data Collection 69 Neoadjuvant Therapy 63 Magnetic Resonance Imaging 62 Immunohistochemistry 62 Immune Checkpoint Inhibitors 56 Watchful Waiting 50 Immunotherapy 50 Bevacizumab 49 Positron Emission Tomography Computed Tomography 46 Ultrasonography 44 Liquid Biopsy 41 Hematologic Tests 41 Radiosurgery 40 Colonoscopy 40 Tomography, X-Ray Computed 39 Therapeutics 39 pembrolizumab 37 Gene Expression Profiling 36 High-Energy Shock Waves 35 Hepatectomy 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05285033 2023-01-06

LURBICLIN

Intergroupe Francophone de Cancerologie Thoracique

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡